PA8633201A1 - Tieno [3,2-b]piridin-6-carbonitrilos como inhibidores de la quinasa proteica - Google Patents
Tieno [3,2-b]piridin-6-carbonitrilos como inhibidores de la quinasa proteicaInfo
- Publication number
- PA8633201A1 PA8633201A1 PA20058633201A PA8633201A PA8633201A1 PA 8633201 A1 PA8633201 A1 PA 8633201A1 PA 20058633201 A PA20058633201 A PA 20058633201A PA 8633201 A PA8633201 A PA 8633201A PA 8633201 A1 PA8633201 A1 PA 8633201A1
- Authority
- PA
- Panama
- Prior art keywords
- carbonitrils
- tieno
- piridin
- inhibitors
- protein kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyridine Compounds (AREA)
Abstract
ESTA INVENCION PROVEE LOS COMPUESTOS DE LA FORMULA II: EN LA CUAL: R1,R2 Y X SON DEFINIDOS EN LO QUE ANTECEDE EN LA MEMORIA DESCRIPTIVA, LOS CUALES SON UTILES EN EL TRATAMIENTO DEL CANCER, ATAQUE APOPLETICO, INFARTO DE MIOCARDIO, DOLOR NEUROPATICO, OSTEOPOROSIS, ENFERMEDAD RENAL POLICISTICA, ENFERMEDAD AUTOINMUNE, ARTRITIS REUMATOIDES, Y RECHAZO DE TRANSPLANTES. LA INVENCION TAMBIEN PROVEE PROCESOS PARA PRODUCIR DICHOS COMPUESTOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/845,710 US7276519B2 (en) | 2002-11-25 | 2004-05-14 | Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8633201A1 true PA8633201A1 (es) | 2006-05-16 |
Family
ID=35149207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20058633201A PA8633201A1 (es) | 2004-05-14 | 2005-05-13 | Tieno [3,2-b]piridin-6-carbonitrilos como inhibidores de la quinasa proteica |
Country Status (20)
Country | Link |
---|---|
US (2) | US7276519B2 (es) |
EP (1) | EP1756117A2 (es) |
JP (1) | JP2007537262A (es) |
KR (1) | KR20070015575A (es) |
CN (1) | CN1950379A (es) |
AR (1) | AR050248A1 (es) |
AU (1) | AU2005245820A1 (es) |
BR (1) | BRPI0511089A (es) |
CA (1) | CA2564530A1 (es) |
CR (1) | CR8787A (es) |
EC (1) | ECSP067087A (es) |
GT (1) | GT200500109A (es) |
MX (1) | MXPA06012900A (es) |
NO (1) | NO20065489L (es) |
PA (1) | PA8633201A1 (es) |
PE (1) | PE20060355A1 (es) |
RU (1) | RU2006137476A (es) |
TW (1) | TW200602348A (es) |
WO (1) | WO2005113560A2 (es) |
ZA (1) | ZA200609422B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1833829A2 (en) | 2004-12-23 | 2007-09-19 | F. Hoffmann-Roche AG | Benzamide substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors |
CN101830899A (zh) * | 2004-12-23 | 2010-09-15 | 霍夫曼-拉罗奇有限公司 | 杂环氨基甲酸酯衍生物,它们的制备及作为药剂的应用 |
AR056200A1 (es) * | 2005-09-27 | 2007-09-26 | Wyeth Corp | Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa |
US20090306373A1 (en) * | 2005-12-20 | 2009-12-10 | Gamber Gabriel G | 4,7-dihydrothieno[2,3-b]pyridine compounds and pharmaceutical compositions |
US20110053931A1 (en) * | 2006-06-08 | 2011-03-03 | John Gaudino | Quinoline compounds and methods of use |
TW200900408A (en) * | 2007-03-02 | 2009-01-01 | Kyowa Hakko Kogyo Kk | Fused pyridine derivative |
WO2009041591A1 (ja) * | 2007-09-28 | 2009-04-02 | Kyowa Hakko Kirin Co., Ltd. | 縮環ピリジン誘導体 |
AR070317A1 (es) * | 2008-02-06 | 2010-03-31 | Osi Pharm Inc | Furo (3,2-c) piridina y tieno (3,2-c) piridinas |
WO2010036629A2 (en) * | 2008-09-26 | 2010-04-01 | National Health Research Institutes | Fused multicyclic compounds as protein kinase inhibitors |
TW201204733A (en) | 2010-06-25 | 2012-02-01 | Kowa Co | Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
ES2606637T3 (es) * | 2012-02-09 | 2017-03-24 | Merck Patent Gmbh | Derivados de furo [3,2- b]piridina como inhibidores de TBK1 e IKK |
WO2014004376A2 (en) | 2012-06-26 | 2014-01-03 | Del Mar Pharmaceuticals | Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof |
DE102013008118A1 (de) | 2013-05-11 | 2014-11-13 | Merck Patent Gmbh | Arylchinazoline |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0126970A3 (en) | 1983-04-27 | 1985-11-06 | Beecham Group Plc | Anxiolytic and anti-depressant thienopyridine derivatives |
AR004010A1 (es) * | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
HUP0100287A3 (en) * | 1997-11-11 | 2003-04-28 | Pfizer Prod Inc | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
CN1144786C (zh) * | 1998-09-29 | 2004-04-07 | 美国氰胺公司 | 作为蛋白质酪氨酸激酶抑制剂的取代的3-氰基喹啉 |
JP3270834B2 (ja) * | 1999-01-27 | 2002-04-02 | ファイザー・プロダクツ・インク | 抗がん剤として有用なヘテロ芳香族二環式誘導体 |
GB9906566D0 (en) | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
ATE264328T1 (de) | 1999-04-21 | 2004-04-15 | Wyeth Corp | Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen |
ATE353320T1 (de) | 1999-12-29 | 2007-02-15 | Wyeth Corp | Tricyclische proteinkinasehemmer |
AR035851A1 (es) | 2000-03-28 | 2004-07-21 | Wyeth Corp | 3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas |
ATE277933T1 (de) | 2000-06-06 | 2004-10-15 | Pfizer Prod Inc | Thiophenverbindungen zur verwendung als antikrebsmittel |
US20020004511A1 (en) | 2000-06-28 | 2002-01-10 | Luzzio Michael Joseph | Thiophene derivatives useful as anticancer agents |
US7253184B2 (en) * | 2000-11-02 | 2007-08-07 | Astrazeneca Ab | 4-Substituted quinolines as antitumor agents |
EP1418917A1 (en) | 2001-08-10 | 2004-05-19 | Novartis AG | Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
CL2003002287A1 (es) * | 2002-11-25 | 2005-01-14 | Wyeth Corp | COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS |
GB0420719D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
MX2007014616A (es) * | 2005-05-20 | 2009-08-12 | Methylgene Inc | Inhibidores de señalizacion del receptor del factor a de crecimiento endotelial vascular y del receptor del factor de crecimiento de hepatocitos. |
AR056200A1 (es) * | 2005-09-27 | 2007-09-26 | Wyeth Corp | Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa |
-
2004
- 2004-05-14 US US10/845,710 patent/US7276519B2/en not_active Expired - Fee Related
-
2005
- 2005-05-10 KR KR1020067023726A patent/KR20070015575A/ko not_active Application Discontinuation
- 2005-05-10 WO PCT/US2005/016150 patent/WO2005113560A2/en active Application Filing
- 2005-05-10 AU AU2005245820A patent/AU2005245820A1/en not_active Withdrawn
- 2005-05-10 MX MXPA06012900A patent/MXPA06012900A/es unknown
- 2005-05-10 RU RU2006137476/04A patent/RU2006137476A/ru not_active Application Discontinuation
- 2005-05-10 JP JP2007513251A patent/JP2007537262A/ja active Pending
- 2005-05-10 CA CA002564530A patent/CA2564530A1/en not_active Abandoned
- 2005-05-10 EP EP05742281A patent/EP1756117A2/en not_active Withdrawn
- 2005-05-10 CN CNA2005800147166A patent/CN1950379A/zh active Pending
- 2005-05-10 GT GT200500109A patent/GT200500109A/es unknown
- 2005-05-10 BR BRPI0511089-0A patent/BRPI0511089A/pt not_active IP Right Cessation
- 2005-05-12 TW TW094115389A patent/TW200602348A/zh unknown
- 2005-05-12 PE PE2005000531A patent/PE20060355A1/es not_active Application Discontinuation
- 2005-05-13 PA PA20058633201A patent/PA8633201A1/es unknown
- 2005-05-13 AR ARP050101971A patent/AR050248A1/es not_active Application Discontinuation
-
2006
- 2006-11-13 ZA ZA200609422A patent/ZA200609422B/en unknown
- 2006-11-28 NO NO20065489A patent/NO20065489L/no unknown
- 2006-12-05 CR CR8787A patent/CR8787A/es not_active Application Discontinuation
- 2006-12-14 EC EC2006007087A patent/ECSP067087A/es unknown
-
2007
- 2007-09-24 US US11/903,754 patent/US20080070913A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CR8787A (es) | 2007-10-02 |
US7276519B2 (en) | 2007-10-02 |
ECSP067087A (es) | 2007-01-26 |
NO20065489L (no) | 2006-11-28 |
PE20060355A1 (es) | 2006-05-11 |
CN1950379A (zh) | 2007-04-18 |
GT200500109A (es) | 2005-12-23 |
MXPA06012900A (es) | 2007-01-26 |
AU2005245820A1 (en) | 2005-12-01 |
WO2005113560A3 (en) | 2006-01-12 |
RU2006137476A (ru) | 2008-06-20 |
EP1756117A2 (en) | 2007-02-28 |
WO2005113560A2 (en) | 2005-12-01 |
TW200602348A (en) | 2006-01-16 |
BRPI0511089A (pt) | 2007-12-26 |
KR20070015575A (ko) | 2007-02-05 |
CA2564530A1 (en) | 2005-12-01 |
US20080070913A1 (en) | 2008-03-20 |
ZA200609422B (en) | 2008-07-30 |
JP2007537262A (ja) | 2007-12-20 |
US20040242883A1 (en) | 2004-12-02 |
AR050248A1 (es) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8633201A1 (es) | Tieno [3,2-b]piridin-6-carbonitrilos como inhibidores de la quinasa proteica | |
ECSP055802A (es) | TIENO[3,2-b]PIRIDIN-6-CARBONITRILOS Y TIENO[2,3-b]PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINA CINASAS | |
CU23464B7 (es) | (1,8)naftidirin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
ECSP056072A (es) | Pirimidinonas sustituidas | |
UY29458A1 (es) | Heterociclos sustituidos y usos de los mismos | |
SV2002000572A (es) | 2- (4-piridil) animo- 6- dialcoxifenil-pirido [2,3-d] pirimidin-7-onas | |
UY31072A1 (es) | Imidazopiridazinas sustituidas como inhibidores de cinasa de lipido | |
UY29653A1 (es) | Nuevos anticuerpos anti-madcam | |
CL2012000917A1 (es) | Compuestos derivados de pirazolo [3,4-d] pirimidina, inhibidores btk; y uso en el tratamiento del cancer, enfermedades autoinmune, mastocitosis,osteoporosis,entre otras. | |
ECSP105178A (es) | Compuestos de aril urea en combinación con otros agentes citostáticos o citotóxicos para el tratamiento de cáncer en humanos | |
SV2005002013A (es) | Inhibidores de proteina quinasas con estructura de 3-quinolincarbonitrilo ref. am101382 | |
UY30430A1 (es) | Compuestos | |
GT200600013A (es) | Compuestos organicos | |
GT200400013A (es) | Compuestos de pirazolotriazina y usos de los mismos | |
GT200400076A (es) | Ligandos de receptores de cannabinoides y sus usos | |
CR9312A (es) | Alargar el tiempo hasta la progresion de la enfermedad o la supervivencia de los pacientes de cancer | |
GT200300289A (es) | Derivados de pirrolopirimidina | |
AR030760A1 (es) | Nuevos acidos y polipeptidos nucleicos receptores | |
CY1110933T1 (el) | 5,7-διαμινοπυραζολο[4,3-d]πυριμιδινες με ανασταλτικη της pde-5 δραστικοτητα | |
ECSP066635A (es) | Quinolinas utiles en el tratamiento de enfermedades cardiovasculares | |
BR0211905A (pt) | Dialdeìdos de rapamicina | |
PA8610601A1 (es) | Compuestos de bencimidazolona que tienen actividad agonista del receptor 5-ht4 | |
CR8288A (es) | 6-[ (sustituido) fenil] triazolopirimidinas como agentes anticancer | |
CY1108649T1 (el) | Υποκατεστημενα αρυλπυραζολια ως παρασιτοκτονα | |
PA8632601A1 (es) | Derivados de pirimidina para tratar el crecimiento celular anómalo |